The Improving Access to Psychological Therapies (IAPT) programme aims to provide evidence-based psychological therapies for people with depression and anxiety disorders. The NHS Information Centre have published the first set of key performance indicators for the programme, which aim to provide the Department of Health, IAPT services, commissioners and members of the public with information on [read the full story…]
There are a number of studies that show the positive impact that cognitive behavioural therapy can have on the symptoms of obsessive-compulsive disorder (OCD). This randomised controlled trial conducted by researchers in Denmark sought to shed some light on the effectiveness of group cognitive behavioural therapy compared to individual CBT. 110 outpatients with OCD were [read the full story…]
Attention deficit hyperactivity disorder (ADHD) is a group of behavioural symptoms that include inattentiveness, hyperactivity and impulsiveness. ADHD is often thought of as a childhood problem, but it can be a lifelong condition, and many children continue to have symptoms as a teenager and adult. It is estimated that nearly two-thirds of children with ADHD [read the full story…]
First generation typical antipsychotics (e.g. chlorpromazine and haloperidol) have historically been used a great deal to treat people with schizophrenia. More recently, second-generation atypical antipsychotics (e.g. risperidone and olanzapine) have been more frequently used. For many, these drug therapies help to reduce psychotic episodes and the overall impact of the illness, but not all patients [read the full story…]
The British Association for Psychopharmacology regularly publish consensus guidelines on the pharmacological treatment of mental health conditions. In the last two years these publications have included guidance on insomnia (PDF), dementia (PDF) and bipolar disorder (PDF). The latest guideline from the BAP is on the pharmacological treatment of schizophrenia and as usual it’s available in full-text [read the full story…]
Psychological therapies given to people with depression, anxiety or mixed disorders in primary care are usually delivered over a shorter time period than in secondary care. In the UK, 6 sessions is a common treatment length, which contrasts to the 12-24 sessions that have been the subject of most trials of psychological therapies in secondary care [read the full story…]
A new meta-analysis published in the African Journal of Psychiatry investigates the efficacy of psychological treatments for depression and anxiety disorders in low and middle income countries. To date there has perhaps existed a view that psychological mindedness is missing amongst the population of developing countries. There is good evidence that psychological treatments work as [read the full story…]
This review was initially picked up by our colleagues over at the Mental Elf who published this on their blog on 7th September. People with severe mental illnesses like schizophrenia or bipolar disorder are over three times more likely to lose their teeth because of poor oral health than the general population. The research, published [read the full story…]
People with severe mental illnesses like schizophrenia or bipolar disorder are over three times more likely to lose their teeth because of poor oral health than the general population. The research, published in the September issue of the British Journal of Psychiatry, shows that psychiatric patients have not shared in recent improvements in dental health. [read the full story…]
Transcranial Magnetic Stimulation (TMS) is a treatment where magnetic coils are placed above the scalp and used to generate magnetic fields, which create short-lasting electrical currents in the brain below the stimulation site. TMS is used to treat a number of health conditions including depression. This meta-analysis conducted by researchers at Oxford University presents an [read the full story…]
